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Abstract
Bilateral neurectomy of the pelvic nerve (BLPN) that carries uterine cervix- related sensory nerves induces dystocia, 
and administration of its vasoactive neuropeptides induces changes in the cervical microvasculature, resembling those 
that occur in the ripening cervix. This study was designed to test the hypothesis that (a) the cervix of pregnant rats 
expresses vascular endothelial growth factor (VEGF) and components of the angiogenic signaling pathway [VEGF 
receptors (Flt-1, KDR), activity of protein kinase B, Akt (phosphorylated Akt), and endothelial nitric oxide synthase 
(eNOS)] and von Willebrand Factor (vWF) and that these molecules undergo changes with pregnancy, and (b) bilateral 
pelvic neurectomy (BLPN) alters levels of VEGF concentration in the cervix. Using RT-PCR and sequencing, two 
VEGF isoforms, 120 and 164, were identified in the rat cervix. VEGF, VEGF receptor-1 (Flt-1), eNOS, and vWF 
immunoreactivities (ir) were localized in the microvasculature of cervical stroma. Their protein levels increased during 
pregnancy but decreased to control levels by 2 days postpartum. VEGF receptor-2 (KDR)-ir was confined to the 
epithelium of the endocervix. BLPN downregulated levels of VEGF by a third. Therefore, the components of the 
angiogenic signaling pathway are expressed in the cervix and change over pregnancy. Furthermore, angiogenic and 
sensory neuronal factors may be important in regulating the dynamic microvasculature in the ripening cervix and may 
subsequently play a role in cervical ripening and the birth process 
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During pregnancy the quiescent uterus provides a 
favorable environment for the growing fetus and the 
nonpliable cervix ensures retention of the fetus in utero. 
However, at term the cervix undergoes tissue remodel- 
ing or cervical ripening with a progressive dissociation 
and disorganization of collagen fibers and bundles 
that leads to softening and dilatation of the cervix. At 
this time the uterus begins to contract and the cervix re- 
laxes, and, collectively, these alterations facilitate a timely 
passage of the fetus at parturition (Kelly 2002). Failure 
or disruption of these processes causes complications 
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at  parturition,  such  as  preterm  or  protracted  labor, 
that account for 75% of all infant deaths (Challis 2000). 
The complexity of cervical ripening is evidenced by 
the  multiplicity  of  factors  involved,  many  of  which 
have been studied extensively, such as nitric oxide, cyto- 
kines, prostaglandins, relaxin, steroid hormones, and 
neuropeptides  (Fuchs  et  al.  1983;  Matsuzaki  et  al. 
1993;  Arntzen  et  al.  1998;  Chaim  and  Mazor  1998; 
Collins  et  al.  2002;  Mowa  et  al.  2003a,b).  However, 
the exact mechanism(s) underlying the initiation and 
progression of cervical ripening remains elusive. More- 
over, deletion of individual genes for key regulatory 
factors hitherto implicated in cervical ripening fail 
to  completely  block  reproductive  processes  in  mice 
(Kimura et al. 1999). 
Uterine cervix-related sensory neurons (but not mo- 
tor neurons) play an important role in parturition in 
that their denervation induces dystocia (Higuchi et al. 
1987; Burden et al. 1990). Exactly how these neu- 
ropeptide-rich neurons influence parturition and cer- 
vical ripening remains to be elucidated. However, 
when the sensory neuropeptide substance P (SP) is ad- 
ministered to rats, it mimics aspects of neurogenic in- 
flammation seen in the parturient cervix (Collins et al. 
2002). Furthermore, production of SP and another 
sensory neuropeptide, calcitonin gene-related peptide 
(CGRP), in uterine cervix-related dorsal root ganglia 
(L6–S1 DRG) and the SP receptor NK1 in the cervix 
increase before parturition, coinciding with the initia- 
tion of cervical ripening (Collins et al. 2002; Mowa et 
al. 2003a,b). Because elimination of uterine cervix- 
related sensory nerves and their transmitters interferes 
with parturition (Higuchi et al. 1987, Burden et al. 
1990) and because these nerves contain the vasoactive 
neuropeptides SP and CGRP (Papka 1990; Papka and 
Traurig 1993; Mowa et al. 2003a,b), which induce 
vascular changes resembling those induced by vascular 
endothelial growth factor (VEGF), we hypothesized the 
existence of a functional link between the sensory 
nerves and angiogenic factors in cervical ripening. 
VEGF (VEGF-A) is a member of a family of closely 
related growth factors that includes VEGF-A, -B, -C, 
-D, -E, and placenta growth factor (PIGF) (Tischer et 
al. 1991; Conn et al. 1990; Park et al. 1994; Shima et 
al. 1996; Ferrara and Davis-Smyth 1997).  VEGF-A 
has several splice variants, i.e., 120, 164, 188, and 205 
representing the number of amino acids (+1 in hu- 
man), and its biological effects have been well estab- 
lished (Ferrara and Davis-Smyth 1997). VEGF 164/ 
165 is the most potent, abundant, and best-character- 
ized variant (although transcripts of VEGF 120 may 
be more abundant in some tissues Zachary and Gliki 
2001). The biological effects of VEGF are largely me- 
diated by two receptors, kinase domain region (KDR) 
and fms-like tyrosine kinase-1 (Flt-1) (de Vries et al. 
1992; Ferrara and Davis-Smyth 1997; Shibuya 1995; 
Mustonen and Alitalo 1995; Shibuya et al. 1999) [a 
third VEGF receptor 3 mediates the effects of VEGF in 
the lymph vessels (Shibuya et al. 1999)]. VEGF in- 
duces angiogenesis primarily via protein kinase B (Akt), 
phosphorylated at serine 473 (Six et al. 2002). Akt 
activates endothelial nitric oxide synthase (eNOS)- 
derived nitric oxide (NO) through phosphorylation 
(Fulton et al. 2002). Consequently, it is essential to 
characterize the VEGF isoforms present in the cervix 
and to profile the basic signaling machinery likely to 
mediate the effects of VEGF. 
The present study was designed to address the hy- 
pothesis that the microvasculature of the uterine cer- 
vix undergoes remodeling during cervical ripening 
which is likely to be regulated, in part, by VEGF. Three 
aims were undertaken for this goal: (a) characteriza- 
tion of VEGF isoforms present in the cervix; (b) local- 
ization and profiling the expression of VEGF and the 
basic VEGF angiogenic signaling factors [VEGF recep- 
tors Flt-1 and KDR, eNOS, and phosphorylated Akt 
(pAkt)] over pregnancy; and (c) determination of the 
effects of transecting the uterine cervix-related sensory 
nerves on VEGF levels in the cervix. 
 
 
Materials and Methods 
Animals 
Timed-pregnant Wistar rats at pregnancy  days  8  (n=10), 
15, 20, 22, and 2 days postpartum were used in these studies 
(n=8 per time-point). Uterine cervical tissues were analyzed 
by immunohistochemistry (IHC), Western blot analysis, 
ELISA, and RT-PCR. To examine links between sensory 
nerves and VEGF, bilateral pelvic neurectomies (BLPNs; 
n=4) were performed on day 9 of pregnancy (described be- 
low) and rats were killed on day 22. BLPN-shams  (n=4) 
were used as controls. All experiments were performed in 
accordance with the Guide for the Care and Use of Labora- 
tory Animals of the local institution and the NIH guidelines 
(NIH publication number 86-23), and efforts were made to 
minimize both animal suffering and numbers of animals 
used. 
Bilateral Pelvic Neurectomy 
Transecting the pelvic nerves bilaterally, to eliminate sensory 
nerves innervating the cervix at gestational day 9, is compat- 
ible with pregnancy but parturition is blocked (Burden et al. 
1990). On day 9 of pregnancy, rats were anesthetized (50 
mg/kg sodium pentobarbital IP) and a laparatomy was per- 
formed to identify the pelvic paracervical ganglion adjacent 
to the junction of the cervix and vagina. The ganglia were 
followed laterally to identify the pelvic nerve, a 5-mm seg- 
ment was removed from the nerve on each side, and the 
wound was closed. The animals were allowed to recover and 
to progress towards term. If animals did not deliver nor- 
mally and showed signs of protracted labor, they were killed 
by an overdose of anesthesia (100 mg/kg sodium pentobar- 
bital IP) and perfused transcardially with saline. The cervices 
were harvested, processed, and evaluated for changes in 
VEGF levels using ELISA. For sham control animals, rats on 
day 9 of pregnancy were handled as in bilateral pelvic neu- 
rectomy above except that the pelvic nerves were touched 
but not transected. 
 
IHC Staining 
Angiogenic Factors. IHC studies were undertaken to deter- 
mine the cellular sites and expression patterns of VEGF, Flt-1, 
KDR, vWF, and eNOS in the cervices of rats in early (day 
10) and late (day 22) pregnancy. After deeply anesthetizing
the animals (ketamine HCl 100 mg/kg IP), the cervices were 
rapidly removed, frozen in liquid nitrogen, and 8-µm-thick 
cryostat sections were cut in a transverse plane. The sections 
were mounted on glass slides, fixed in acetone for 10 min at 
4C,  air-dried  and  processed  for  IHC.  Commercially  avail- 
able and well-characterized (Jesmin et al. 2003) antibodies 
were used [VEGF, rabbit generated against human poly- 
clonal antibodies (Immunological Laboratories, Fujioka, Ja- 
pan); KDR and Flt-1, rabbit generated against human poly- 
clonal antibodies (Santa Cruz Biotechnology; Santa Cruz, 
CA); eNOS, rabbit generated against human polyclonal anti- 
bodies (Affinity BioReagents; Golden, CT)]. To prevent non- 
specific staining, the sections were blocked by nonimmune 
serum (1% bovine serum albumin in Tris) for 30 min  at 
room temperature. After overnight incubation at 4C with 
primary antibodies, the sections were rinsed in phosphate 
buffer solution and then exposed to the secondary antibody, 
Cy3-conjugated AffiniPure goat anti-rabbit IgG or fluores- 
cein isothiocyante (FITC)-conjugated AffiniPure goat anti- 
rabbit IgG (Jackson Immunoresearch Laboratories; West 
Grove, PA) for 2 hr according to the manufacturer’s instruc- 
tions. Sections processed without primary antibodies served 
as negative controls. The coverslips were mounted with Im- 
munon (Thermo Shandon; Pittsburgh, PA). Immunofluores- 
cent images were viewed using a laser scanning confocal im- 
aging system (model MRC-1024; Bio-Rad, Hertfordshire, 
UK). In some cases serial sections were stained with hema- 
toxylin and eosin (H and E) and antibodies to identify the 
cell types expressing the proteins of interest. 
Capillary Morphology. To identify and assess capillary 
morphology and expansion, some cervices were fixed and ei- 
ther frozen and sectioned or embedded in paraffin and sec- 
tioned and immunostained with vWF, a marker for endothe- 
lial cells. After immunostaining with vWF primary antibody 
(goat generated against mouse antibody; DAKO, Hamburg, 
Germany), sections were incubated with Cy3-conjugated Af- 
finiPure donkey anti-rabbit IgG (Jackson Immunoresearch 
Laboratories). 
Western Blot Analysis 
Angiogenic Factors. Western blot analysis was used to 
complement immunohistochemical experiments by facilitat- 
ing the quantification of the angiogenic factors in the cervix 
at different time points of pregnancy [days 8, 15, 20, and 22 
of pregnancy and 2 days postpartum (2dp)]. After removing 
and rinsing the cervices in ice-cold PBS, the tissues were 
minced with scissors, homogenized, and centrifuged at 
500 x g for 15 min to pellet any insoluble material. The 
protein concentration of the supernatants was determined 
using the bicinchoninic acid protein assay (Pierce; Rockford, 
IL). Samples were run on SDS-PAGE using a 7.5–15% poly- 
acrylamide gel and electrotransferred to polyvinylidine diflu- 
oride filter (PVDF) membrane. To reduce nonspecific bind- 
ing, the PVDF was blocked for 2 hr at RT with 5% nonfat 
milk in PBS containing 0.1% Tween-20 (TPBS). The PVDF 
was incubated overnight at 4C with specific antibodies for 
VEGF, KDR, Flt-1, and eNOS (as described above; 1:100– 
1,000 dilution) in TPBS, washed thrice in TPBS, and then in- 
cubated with horseradish peroxidase-conjugated anti-rabbit 
antibody (Amersham; Poole, UK) diluted at 1: 2000–10,000 
in TPBS at RT for 60 min. The blots were visualized with 
the enhanced chemiluminescence detection system (Amer- 
sham), exposed to X-ray film, and analyzed by free NIH im- 
age software. 
ELISA 
ELISA, a sensitive technique for determining tissue protein con- 
centration, was used to determine VEGF and phosphorylated 
Akt (pAkt) protein concentration in the cervices of pregnant rats. 
VEGF. VEGF levels in the rat cervices of pregnant, bilateral 
pelvic neurectomy (BLPN), and BLPN-sham rats (n=4) were 
estimated using a commercially available ELISA kit (VEGF 
Immunoassay; R and D Systems, Minneapolis, MN) accord- 
ing to the manufacturers’ instructions. 
Phosphorylated Akt. The level of protein kinase B (Akt), 
phosphorylated by VEGF at serine residue 473, in tissue ex- 
tracts of cervices of pregnant rats, was estimated by ELISA 
Akt kit [pS473] (BioSource International; Richmond, CA). 
Semiquantitative  RT-PCR 
Primers for RT-PCR were designed to detect all five isoforms 
of VEGF (Burchardt et al. 1999) to screen VEGF variants ex- 
pressed in the cervix around the onset of cervical ripening. 
The lung and penis, which express various VEGF variants, 
were used as positive control tissues (Burchardt et al. 1999). 
mRNA: PCR. Total RNA Isolation. Rats in late (day 20) 
pregnancy were anesthetized and perfused only with saline. 
The cervices were removed and stored at -80C until pro- 
cessing. Total RNA was isolated from cervices of individual 
animals using the RNeasy Mini Kit (Qiagen; Valencia, CA). 
The amount and purity of total RNA for each sample were 
estimated by spectrophotometric analysis at A260 and A280. 
The quality of RNA was determined by agarose gel electro- 
phoresis after ethidium bromide staining. Aliquots of total 
RNA were diluted in diethylpyrocarbonated (DEPC)-treated 
water and stored at -80C. 
Semiquantitative RT-PCR. RT-PCR was utilized to iden- 
tify VEGF isoforms present in the cervix using rats at day 20 
of pregnancy. Total RNA was reversed-transcribed and am- 
plified in an Eppendorf Master Cycler, using reagents from 
Gene AMP Gold RNA PCR Kit (PE BioSystems; Foster City, 
CA). Briefly, 0.5–1 µg total RNA was reverse transcribed 
and amplified in a 50 µl reaction mixture containing the 
following: 5 x RT-PCR buffer, 1.75 mM MgCl2, 1.2 mM 
dNTPs, 10 U RNase inhibitor, 5.0 mM DTT, 1 µM random 
hexamer, 200 nM VEGF (forward, 5'-TGC-ACC-CAC- 
GAC-AGA-AGG-GGA-3'), 200 nM VEGF (reverse, 5'- TCA-
CCG-CCT-TGG-CTT-GTC-ACA-3'),    5.0    U    AmpliTaq 
Gold DNA polymerase, 30 U MultiScribe reverse transcriptase, 
and DEPC-treated water. The RT-PCR reaction was normal- 
ized across the runs using GAPDH gene (Primers: forward, 5'- 
GAG-GAC-CAG-GTT-GTC-TCC-TG-3'; reverse, 5'-GGA- TGG-
AAT-TGT-GAG-GGA-GA-3')  as  a  standard.  The  PCR 
products were separated using agarose gel electrophoresis, visu- 
alized after staining with SYBR Green 1, and scanned using the 
Kodak 1D Image Station  (Rochester,  NY).  The  cDNA  bands 
for VEGF were isolated from the gel and sequenced. 
Statistical Analysis 
Values are shown as means + SD. Statistical analysis was 
performed by ANOVA with multiple comparisons by Fisher’s 
protected least-significant difference t-test. Nonparametric 
data were analyzed by the Mann-Whitney’s U-test or Wil- 
coxon signed-rank test. A p<0.05 was considered significant. 
Results 
The Rat Cervix Contains VEGF 120 and 164 
RT-PCR primers designed to detect all VEGF isoforms 
revealed the presence of VEGF-A splice variants 120 
and 164 (Figure 1), with VEGF 164 being the predom- 
inant type in the cervix. The bands corresponded to 
those demonstrated from adult male lung and penis 
that were used as positive control tissues (Figure 1). 
The bands of the VEGF-A splice variants from the cer- 
vix were isolated from their electrophoresis gel, se- 
quenced, and blasted, to determine their specific base 
pairs. A faint band, with a molecular weight corre- 
sponding to that of VEGF 188, was observed in cervi- 
ces sampled from parturient rats (data not shown). 
However, this band could not be confirmed by se- 
quencing. 
vWF Expression in the Cervical Microvasculature 
Changes During Pregnancy 
vWF was used as a marker for endothelial cells to vi- 
sualize the patterns and magnitude of capillary expan- 
sion that occur in the cervix during pregnancy. vWF 
immunolabeling was localized in the microvasculature 
of the endocervix and the base of the luminal epithelia 
of the cervix (Figures 2A and 2B). The relative abun- 
dance of expression of vWF appeared to increase over 
pregnancy (compare Figures 2A and 2B). Blood ves- 
sels immunolabeled with vWF tended to “aggregate” 
by day 22 of pregnancy, forming spindle-shaped struc- 
tures (Figure 2B). The distribution pattern of vWF 
overlapped with those of VEGF receptors (Flt-1 and 
KDR; Figures 2E, 2F and 2G, 2H, respectively) and 
eNOS (Figures 2I and 2J), based on serial sections 
stained with H and E and the respective angiogenic 
molecules (H and E histology not shown). 
VEGF Localization and Increases over the Course 
of Pregnancy 
VEGF was localized by IHC to the stromal cells, largely 
in the endocervix, at days 8 and 22 of pregnancy (Fig- 
Figure 1 Characterization, using RT-PCR, of VEGF in the cervix (C). 
Two VEGF-A splice variants, VEGF-120 and -164, were identified in 
the cervix in late (day 20) pregnancy, with VEGF 164 being the pre- 
dominant variant. The lung (L) and penis (P) of adult  male  rats, 
which predominantly express VEGF-188 and -164, respectively, 
were used as positive control tissues. The cDNA bands on the gel 
were identified on the basis of their molecular weight, after which 
they were isolated, sequenced, and blasted, to further  confirm 
their identity. Bp, base pair. GAPDH gene was used as a normalizer. 
ures 2C and 2D). VEGF was not visualized in the lu- 
minal epithelia of the cervix (Figures 2C and 2D). Pro- 
files of the stromal cells expressing immunoreactivity 
for VEGF increased with advancing pregnancy, as re- 
vealed by IHC (Figures 2C and 2D). These IHC find- 
ings were corroborated by the Western blot and im- 
munoassay data, both of which revealed an increase in 
VEGF levels between day 8 and days 15, 20, and 22 of 
pregnancy, with a decrease by 2 days postpartum (Fig- 
ures 3A and 4A). The difference in relative levels of 
VEGF at days 15, 20, and 22 of pregnancy and at 2 
days postpartum vs day 8 were statistically significant 
(p<0.05). 
VEGF Angiogenic Signaling Factors Increase in the 
Cervix During Pregnancy 
VEGF Receptors. Flt-1 was localized in the micro- 
vasculature of the endocervix and the base of luminal 
epithelia on days 8 and 22 of pregnancy (Figures 2E 
and 2F). The immunostaining in the epithelium as well 
as the profiles of the microvasculature expressing Flt-1 
appeared to increase by late pregnancy (compare Fig- 
ures 2E and 2F), similar to the profiles immunoreac- 
tive for VEGF (Figures 2C and 2D). Western blots showed 
that Flt-1 increased between days 8 and 15, was un- 
changed between days 15 and 20, increased signifi- 
cantly between days 20 and 22, and then returned to 
day 8 levels by 2 days postpartum (Figure 3B). 
Figure 2 Immunohistochemistry. Cryostat sections of the cervix from pregnant rats at days 8 (A,C,E,G,I) and 22 (B,D,F,H,J) of pregnancy im- 
munostained for von Willebrand factor (vWF) (A,B), VEGF (C,D), Flt-1 (E,F), KDR (G,H), and eNOS (I,J). vWF immunolabeling (A,B) was local- 
ized to the microvasculature of the endocervix (arrows) and the base (*) of the luminal epithelia (e) of the cervix. The profiles of vWF immu- 
noreactivity appeared to increase by late pregnancy (B) relative to early pregnancy (A). Vessels immunolabeled for vWF tended to 
“aggregate”, forming spindle-shaped structures (arrows) (B). VEGF was localized (C,D) to the stromal cells of the endocervix (arrows). VEGF 
was not visualized in the luminal epithelia (e) of the cervix. The profiles of VEGF immunoreactivity (arrows) markedly increased in late preg- 
nancy (compare C and D). Flt-1 immunoreactivity was localized (E,F) to the microvasculature of the endocervix and close to the base (*) of 
luminal epithelia (e) on days 8 and 22 of pregnancy. The intensity of Flt-1 immunoreactivity appeared to increase in late pregnancy (com- 
pare E and F). KDR immunoreactivity was concentrated largely at the base (*) of the luminal epithelia (e) of the cervix in early pregnancy, 
but appeared to extend to the microvasculature of the endocervix in late pregnancy (G,H, arrows). Endothelial NOS immunoreactivity (I,J) 
was expressed in the microvasculature of the endocervix (arrows) and appeared to moderately increase in relative abundance in late preg- 
nancy (compare I and J). *, base of luminal epithelia (e); cc, cervical canal. Bar = 50 µm. 

Figure 3 Western blot analysis 
showed that overall levels of all the 
molecules studied increased over the 
course of pregnancy. (A) When ex- 
pressed as a percentage of day 8 lev- 
els, VEGF increased by 100% at days 
15 and 20 and by 300% at day 22, but 
decreased to day 8 levels by 2dp 
(p<0.05). (B) Flt-1 levels, expressed as 
a percentage of day 8 levels, in- 
creased 100% by days 15 and 20, and 
by 300% at day 22, but decreased to 
day 15 levels by 2dp. (C) When ex- 
pressed as a percentage of day 8, KDR 
levels in the cervix increased 300% by 
day 15, 400% by day 20, 500% by day 
22, and were falling by 2dp. (D) Endo- 
thelial NOS levels, expressed as a per- 
centage of day 8 levels,  increased 
200% at days 15 and 20 and by more 
than 300% at day  22,  but  decreased 
to day 8 levels by 2dp (n=5; p<0.05). 
KDR. KDR immunoreactivity was obvious at early 
and late pregnancy and was concentrated close to the 
base of the luminal epithelia of the cervix (Figures 2G 
and 2H). By late pregnancy, however, KDR immu- 
noreactivity extended to the microvasculature of the 
endocervix (Figures 2G and 2H). As shown by West- 
ern blotting the relative abundance of KDR protein in- 
creased in late pregnancy (Figure 3C). 
VEGF Signaling Molecules pAkt and eNOS In- 
crease over the Course of Pregnancy. Endothelial 
NOS immunoreactivity was expressed in the micro- 
vasculature of the endocervix and appeared to in- 
crease moderately in relative abundance in late preg- 
nancy, (day 8 vs day 22 of pregnancy (Figures 2I and 
2J). Endothelial NOS levels, when analyzed by West- 
ern blots, were markedly increased over pregnancy 
(Figure 3D). For example, when expressed as a per- 
centage of day 8 levels, eNOS increased 200% at day 
15 and 20 and by 300% at day 22, and then returned 
to day 8 levels by 2 days postpartum (Figure 3D). 
Akt activity (as revealed by pAkt levels), expressed 
as a percentage of day 8 levels, increased by greater 
than 700% on day 20 but remained at levels close to 
those of day 8 on days 15, 22, and 2 days postpartum 
(Figure 4C). 
Bilateral Pelvic Neurectomy Downregulates Levels of 
VEGF at Parturition 
After BLPN at day 9, levels of VEGF protein in the 
uterine cervix at day 22 of pregnancy decreased by 
about a third compared with the BLPN-sham control 
animals (Figure 4B). 
Discussion 
The important findings of this study are as follows: (a) 
The rat cervix expresses two VEGF-A splice variants, 
VEGF  164  (predominant  type)  and  VEGF  120,  (b) 
VEGF  and  its  signaling  molecules  Flt-1,  KDR,  eNOS, 
and activity of Akt (pAkt levels) increase with advanc- 
ing pregnancy, peaking at the time of cervical ripening 
and parturition and then returning to base levels by 2 
days postpartum, (c) in BLPN pregnant rats, levels of 
VEGF protein are lower than in intact pregnant rats. 
Collectively, these findings have led us to suggest that 
VEGF and its downstream signaling molecules could 
play a role in cervical ripening and that sensory nerves 
could influence parturition through actions on VEGF. 
Angiogenesis, the development of new blood ves- 
sels from preexisting ones (Carmeliet and Jain 2000; 
Ferrara 2001), is a complex and tightly controlled 
process  that  occurs  under  both  physiological  and 
pathological conditions (Ferrara and Alitalo 1999). It 
involves  endothelial  cell  survival,  proliferation,  and 
migration, which in the VEGF system are regulated by 
independent signaling pathways (Ferrara 2001). A key 
effector molecule of angiogenesis is VEGF. To visual- 
ize the microvasculature of the cervix we used immu- 
nostaining for vWF. There was a marked increase in 
the abundance of vWF-ir profiles over pregnancy, a 
finding we interpret as an indicator of expansion of 
the microvasculature in the endocervix over pregnancy. 
This indirectly implies that the changes occurring in 
the cervix during the ripening process may involve an- 
giogenesis.  Because  cervical  ripening  entails  a  con- 
trolled inflammation-like process (Liggins 1981) and 
angiogenesis is intimately associated with inflamma- 
Figure 4 ELISA,  illustrating protein  concentration of VEGF over 
pregnancy (A) and after bilateral pelvic neurectomy (BLPN; B) and 
concentration of phosphorylated (activated)  protein  kinase  B 
(pAkt; C) in the cervix. When expressed as a percentage of day 8 
levels, VEGF (A) increased by 600% at day 15, 700% by day 20, and 
by 1300% at day 22, but decreased to levels less than day 8 by 2dp 
(p<0.05). VEGF protein levels in the cervix were downregulated at 
day 22 of pregnancy after BLPN (B) performed at day 9 of preg- 
nancy compared with sham controls. Levels of phosphorylated Akt 
(or activity) (C), expressed as a percentage of day 8 levels, increased 
by greater than 700% on day 20 but remained lower on days 15 
and 22 of pregnancy and 2dp (n=5; p<0.05). 
tion (McDonald 2001), angiogenesis could be an im- 
portant component of cervical ripening. These data 
provide the groundwork for future studies, which will 
examine specific patterns of endothelial cell activity, 
proliferation, and migration in the cervix during preg- 
nancy and their impact on cervical ripening. 
VEGF plays a critical role in angiogenesis and other 
vascular events, in part, by regulating proliferation, 
migration, and remodeling of endothelial cells (Fer- 
rara et al. 1996; Ferrara and Davis-Smyth 1997; Fer- 
rara, 2001). In female reproductive organs, VEGF me- 
diates cyclical growth of blood vessels (Ferrara et al. 
1998), e.g., treatment of rodents with a VEGF inhibi- 
tor [mFlt-(1-3)-IgG] virtually blocks ovarian corpus 
luteum angiogenesis and maturation of the uterine en- 
dometrium (Ferrara et al. 1998). With regard to the 
cervix, recruitment or mobilization of leukocytes into 
the cervical connective tissue at cervical ripening re- 
quires structural changes to the vasculature. These 
changes resemble those vascular alterations induced 
by VEGF, such as angiogenesis, vascular leakage, and 
vasodilation (Bates and Curry 1997; Murohara et al. 
1998). Consequently, VEGF could play a role in the 
remodeling of cervical microvasculature during cervi- 
cal ripening. The present study identified two VEGF-A 
splice variants, 120 and 164, in the cervix and demon- 
strated that the levels of total VEGF protein increased 
during late pregnancy, coincident with the expansion 
of cervical microvasculature during pregnancy. VEGF- 
120 and VEGF-164 have similar receptor binding 
characteristics, although they possess distinct proper- 
ties that could influence their capacity to function in 
the ever-changing biochemical environment of the 
ripening cervix. For example, whereas VEGF-120 is 
acidic, fails to bind to heparin, and is freely diffusible 
(Robinson and Stringer 2001), VEGF-164 is basic, 
binds to heparin and, although secreted, has signifi- 
cant portions bound to the cell surface and extracellu- 
lar matrix (Robinson and Stringer 2001). Because 
VEGF-164 is the most abundant in the cervix and has 
optimal characteristics for bioavailability and biologi- 
cal potency, it is likely to be the most important splice 
variant in the cervix. However, it is not yet clear 
whether VEGF-120 or VEGF-164, or both, are func- 
tionally critical in the cervix in late pregnancy. 
Consistent with the profile of their ligand VEGF, 
levels of VEGF receptors, KDR and Flt-1, increased in 
the cervix over pregnancy. These findings correlate 
with the expansion of cervical microvasculature dem- 
onstrated by increased vWF immunoreactivity. Collec- 
tively, these findings suggest that VEGF may underlie 
the expansion of the microvasculature during cervical 
ripening. Both KDR and Flt-1 have high affinities for 
VEGF, even though that of Flt-1 is higher than KDR 
(Terman et al. 1992; Seetharam et al. 1995; Shibuya 
1995; Shibuya et al. 1999). Paradoxically, Flt-1 is 
more weakly phosphorylated by VEGF than is  KDR 
and is, for this reason, considered to be a “decoy” re- 
ceptor (Walternberger et al. 1994). Moreover, data 
from knockout mice demonstrate that both receptors 
(KDR and Flt-1) are essential for embryonic vascular 
development (Shalaby et al. 1995; Fong et al. 1999). 
At this point, the specific roles of KDR and Flt-1 in 
the cervix are unknown. 
The parallel increase in VEGF and its receptors is in- 
dicative of an activated VEGF signaling. The activated 
form of the serine/threonine protein kinase B, Akt, is an 
attractive marker of VEGF signaling in that it is a criti- 
cal downstream intermediate effector molecule that 
mediates multiple VEGF-induced cellular responses, in- 
cluding angiogenic processes and vascular permeability 
(Six et al. 2002). Consistent with our assumption, a re- 
markable correlation was found between the pattern of 
Akt activity (pAkt levels) and levels of VEGF/KDR/Flt-1 
in the cervix over pregnancy. Together, these data sup- 
port the existence of active VEGF/Akt signaling in the 
cervix during late pregnancy. 
The role of NO in cervical ripening is well estab- 
lished (Dong et al. 1996; Yallampalli et al. 1996,1998; 
Ali et al. 1997; Kelly 2002; Maul et al. 2003; Tenore 
2003). However, much of what we know about the 
role of NO in cervical events is based on its nonvascu- 
lar effects, likely mediated by NO produced via induc- 
ible NOS (Yallampalli et al. 1996; Ali et al. 1997). 
NO in the ripening cervix may also arise from the en- 
dothelial cells, as demonstrated in the present study. 
Several recent reports have implicated eNOS-derived 
NO as a terminal effector molecule mediating various 
VEGF-induced vascular responses (Ziche et al., 1997; 
van der Zee et al., 1997; Tsurumi et al., 1997; Goli- 
gorsky et al. 1999; Servos et al. 1999) and that Akt 
phosphorylates eNOS at serine 1176 (Fulton et al. 
2002). Indeed, the importance of eNOS in VEGF sig- 
naling is underscored by findings that mice lacking 
eNOS are resistant to VEGF-induced effects (Yang et 
al. 2001). Although in the present study the activated 
form of eNOS was not determined, levels of total 
eNOS protein correlated with those of VEGF, VEGF 
receptors, and pAkt. Consistent with our conclusion 
above, the correlation between VEGF/VEGF receptors, 
Akt activity, and levels of eNOS strongly suggests the 
presence of an active VEGF/Akt/eNOS signaling cas- 
cade in the ripening cervix; this could mediate vascu- 
lar changes leading to increased leukocyte influx and 
enhanced cervical ripening. The precise mechanisms 
for the marked increase in VEGF and its signaling 
molecules reported here are not yet completely clear. 
Many factors stimulate VEGF production, includ- 
ing interleukin-1, endothelin-1, calcium ions, phorbol 
esters, cytokines (PDGF, TGF, bFGF), heavy metals, 
hypoxia, and sex steroid hormones, e.g., estrogen (Toi 
1995; Gu and Adair 1997; Detmar et al. 1997; Sand- 
ner et al. 1997; Christou et al. 1998; Okuda et al. 
1998; Mueller et al. 2000). An important finding de- 
rived from the present study is that VEGF, in the cer- 
vix of pregnant rats, is influenced by sensory nerves. 
While recent observations indicate that VEGF directly 
stimulate  growth,  survival  and  axonal  outgrowth  of 
neurons and glial cells (Carmeliet and Storkebaum 
2002), to our knowledge, this study is the first to 
show that neuronal factors may have reciprocal effects 
on VEGF expression in peripheral tissues. Although, 
admittedly, it is too premature to speculate mecha- 
nisms that may underlie this effect at this point, it 
is possible that the vasoactive neuropeptides derived 
from cervix-related dorsal root ganglia, e.g., SP and 
CGRP, may account for this phenomenon for the 
following reasons: (a) SP has been shown to induce 
angiogenesis in the lungs (McDonald et al. 1996). 
However, it is important to state that it is  not  yet 
clear whether SP influences angiogenesis by acting via 
VEGF, (b) we previously have shown that when SP is 
administered to ovariectomized rats, it induces some 
of the “classical” vascular changes induced by VEGF, 
such as vascular leakage and vasodilation (Papka et al. 
2001; Collins et al. 2002), (c) the close anatomic rela- 
tionship between nerve terminals immunoreactive to 
SP and CGRP, their receptors, and the cervical mi- 
crovasculature (Papka and Traurig 1993; Collins et al. 
2000,2002; Pokabla et al. 2002; Mowa and Papka 
2004) and stromal cells, which have been shown to 
express VEGF, (d) the temporal and spatial relation- 
ship between vasoactive  neuropeptides  (SP,  CGRP) 
in uterine cervix-related DRG (Mowa et al. 2003a,b) 
and VEGF (present study). Whether the effect of 
BLPN on parturition (dystocia) is due to disruption of 
VEGF signaling, is yet to be confirmed. It is likely that 
VEGF signaling may be one of the mechanisms under- 
lying this phenomenon since BLPN does not com- 
pletely attenuate levels of VEGF in the cervix. VEGF 
levels are also likely to be influenced by high levels of 
circulating estrogen in late pregnancy. Studies on the 
potential mechanisms underlying the link between 
sensory nerves and angiogenic factors during cervical 
ripening are currently ongoing in our lab. 
In conclusion, this study has shown that angiogenic 
molecules are increased over the course of pregnancy 
and peak during the time of cervical ripening. More- 
over, the important factor VEGF is downregulated 
when the pelvic nerves are eliminated. Consequently, 
the dystocia seen with BLPN may be related to a re- 
duction in angiogenic factors and events. Moreover, 
the data derived from this study provide the rationale 
to determine the specific roles of VEGF-120 and VEGF- 
164 signaling mechanisms in cervical ripening. 
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